Onconova

ONTX NASDAQ
3.180
-0.090
-2.75%
Closed 16:00 05/24 EDT
Open
3.374
Prev Close
3.270
High
3.374
Low
3.120
Volume
19.89K
Avg Vol (3M)
74.51K
52 Week High
11.17
52 Week Low
1.690
% Turnover
0.33%
Market Cap
19.08M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
MORE >

Recently

Name
Price
%Change